ArticleJournal of nanobiotechnology2022

Correction to: Bone‑targeted erythrocyte‑cancer hybrid membrane‑camouflaged nanoparticles for enhancing photothermal and hypoxia‑activated chemotherapy of bone invasion by OSCC.

Hongying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.